| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT00722553 |
| P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
| P17 | country | Spain | Q29 |
| United States of America | Q30 | ||
| Belgium | Q31 | ||
| France | Q142 | ||
| Croatia | Q224 | ||
| Argentina | Q414 | ||
| P582 | end time | 2011-04-01 | |
| P921 | main subject | cystitis | Q246084 |
| P1050 | medical condition | carcinoma | Q33525 |
| P2899 | minimum age | 18 | |
| P1132 | number of participants | 30 | |
| P4844 | research intervention | folic acid | Q127060 |
| P6153 | research site | Institut Gustave Roussy | Q266227 |
| hôpital Foch | Q3145155 | ||
| Hospital Universitario Virgen del Rocío | Q3145371 | ||
| Institut Sainte Catherine | Q30273611 | ||
| Centre Oscar Lambret | Q30296137 | ||
| P580 | start time | 2008-07-01 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | A Phase 2, Single-Arm Study of Pralatrexate in Patients With Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder |
Search more.